Contributor Page
McDermott Will & Emery
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 7568000
Fax: +1 202 7568087
The McDermott Building
500 North Capitol Street, N.W.
Washington, DC
20001
United States
By Diane Morgenthaler, Todd Solomon
CHICAGO, IL (October 9, 2017) – Since the announcement by the Internal Revenue Service (IRS) that sponsors of individually designed retirement plans may no longer receive a periodic determination letter...
By Michael Peregrine
Numerous elements of the Equifax controversy implicate corporate governance across a broad range of oversight...
By McDermott Will & Emery
Wrapping Up September – and Looking Forward to October
By Stephen Kranz, Diann Smith, Eric Carstens
On October 1, 2017, the Delaware Department of Finance published final regulations in the Register of Regulations repealing its former unclaimed property regulations and promulgating...
By Diane Morgenthaler, Rick Stepanovic
According to U.S. News & World Report, estimates for the cost of Hurricane Harvey's damage have come in as high as $190 billion, and damage estimates for Hurricane Irma are still rolling...
By William Friedman
On September 28, 2017, the US Department of Energy (DOE) submitted a proposed rule to the Federal Energy Regulatory Commission (FERC) that, if implemented, could reshape organized wholesale electricity markets.
By David Quinn Gacioch
Over the last several months, a handful of federal court decisions...
By Kay Kemp, Diane Morgenthaler
The Internal Revenue Service (IRS) recently extended the temporary nondiscrimination relief for closed defined benefit plans.
By Stephen Kranz, Diann Smith, Eric Carstens
On October 2, 2017, the State of South Dakota (State) filed its petition for a writ of certiorari with the United States Supreme Court (Court).
By Louise-Astrid Aberg, Gregory Heltzer
On February 14, 2017, Integra agreed to purchase Johnson & Johnson's Codman neurosurgery business (excluding Codman's neurovascular and drug deliver businesses) for $1.045 billion.
By Dale Van Demark
A recent article in Kaiser Health News highlights the health risks associated with the increased effort to get patients home—namely...
By Casey Campbell
The Patent Trial and Appeal Board (PTAB) designated as precedential its 2013 decision that assignor estoppel is not a defense for patent owners in inter partes review (IPR) proceedings.
By Danny Mansour
In a precedential decision, the PTAB upheld the longstanding US PTO practice of using a lower threshold to assess claim indefiniteness during prosecution relative to the Nautilus standard applied by courts.
By Paul Devinsky
In June 2017, a panel of the US Court of Appeals for the Federal Circuit ruled that under 35 USC § 145, a court can award attorneys' fees to the US Patent and Trademark Office (PTO)...
By Christopher Lahiff
On September 29, 2017, the US Food & Drug Administration (FDA) announced a proposal to extend the compliance dates for the Nutrition Facts and Supplement Facts label final rule and the Serving Size final rule.
Contributor's Topics
More...